The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 336:747-754 March 13, 1997 Number 11
NextNext

The Incidence of Transfusion-Associated Hepatitis G Virus Infection and Its Relation to Liver Disease
Harvey J. Alter, M.D., Yoshiyuki Nakatsuji, M.D., Jacqueline Melpolder, M.T.(A.S.C.P.), John Wages, M.S., Robert Wesley, Ph.D., J. Wai-Kuo Shih, Ph.D., and Jungsuh P. Kim, Ph.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background The role of hepatitis G virus (HGV) in transfusion-associated infection and its relation to liver disease are not well understood.

Methods Serum samples collected between 1972 and 1995 from 357 transfusion recipients, 157 controls who did not receive transfusions, 500 randomly selected volunteer blood donors, and 230 donors of blood received by HGV-infected patients were tested for HGV RNA by qualitative and quantitative polymerase-chain-reaction assays. Samples obtained before transfusion and serially after transfusion from 79 of the 81 transfusion recipients who had transfusion-associated non-A, non-B hepatitis were available for testing.

Results Of the 79 patients with transfusion-associated hepatitis, 63 (80 percent) had infections related to the hepatitis C virus (HCV) and 3 had preexisting HCV and the cause of their acute hepatitis could not be determined; of the remaining 13 patients, 3 had acute HGV infection, and 10 were infected with unidentified agents. Six of the 63 patients with HCV infection who were tested (10 percent) were also infected with HGV. The three patients infected only with HGV had mild hepatitis (mean peak alanine aminotransferase level, 198 U per liter; none had jaundice); the levels of alanine aminotransferase and HGV RNA were not well correlated. The combined HCV and HGV infections were no more severe than HCV infections alone; the alanine aminotransferase values paralleled the levels of HCV RNA, but not those of HGV RNA. There were 35 HGV infections among the 357 transfusion recipients; only 3 had hepatitis with HGV as the sole viral marker. One of the 157 controls and 7 of the 500 randomly selected blood donors (1.4 percent) had detectable HGV RNA. In all eight instances in which a transfusion recipient had acute HGV infection after transfusion and samples from all donors could be tested, at least one HGV-positive donor was identified.

Conclusions HGV was common in a group of volunteer blood donors, and it can be transmitted by transfusion. Most HGV infections were not associated with hepatitis. HGV did not worsen the course of concurrent HCV infection. No causal relation between HGV and hepatitis has been established.


Source Information

From the Departments of Transfusion Medicine (H.J.A., Y.N., J.M., J.W.-K.S.) and Information Systems (R.W.), Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Md.; and Genelabs Technologies, Redwood City, Calif. (J.W., J.P.K.).

Address reprint requests to Dr. Alter at the Department of Transfusion Medicine, Bldg. 10, Rm. 1C-711, National Institutes of Health, Bethesda, MD 20892.

Full Text of this Article


Related Letters:

Hepatitis G Infection
Kudo T., Morishima T., Shibata M., Goedert J. J., Steinmeyer L. A., Nakatsuji Y.
Extract | Full Text  
N Engl J Med 1997; 337:276-277, Jul 24, 1997. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.